Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus

计划入组 37 人 · 首次发布于 2025 年 4 月 6 日

Post-Transplant Diabetes Outcomes Prediction

计划入组 120 人 · 首次发布于 2026 年 4 月 6 日

Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus

首次发布于 2010 年 7 月 20 日

TBM-TRANSPLANT (Heart)

TBM-TRANSPLANT (Lung)

VETO Kidney Transplant

Transplant Genomics Inc.

United States

WOMB TRANSPLANT UK

United Kingdom

MUSCULOSKELETAL TRANSPLANT FOUNDATION

United States

LifeMine Therapeutics Raises $263M to Advance Novel Calcineurin Inhibitor LIFE-001 for Organ Transplant Rejection

Cures Within Reach Funds Five Drug Repurposing Trials in Chicago to Address Unmet Medical Needs

Viracta Therapeutics' Nana-Val Shows Promise in Post-Transplant Lymphoproliferative Disorder